torovirus
gastroenter
caus
agent
infect
differ
anim
speci
human
date
littl
known
torovirus
caus
diseas
describ
first
time
prototyp
member
genu
equin
toroviru
bern
viru
bev
induc
apoptosi
infect
cell
late
time
postinfect
observ
bev
infect
cell
electron
microscopi
reveal
hour
postinfect
cell
exhibit
morpholog
characterist
apoptot
cell
base
find
analyz
sever
apoptot
marker
observ
protein
synthesi
inhibit
rrna
dna
degrad
nuclear
fragment
caspasemedi
cleavag
parp
pkr
phosphoryl
process
take
place
peak
viru
product
also
determin
cell
death
receptor
mitochondri
pathway
involv
apoptosi
process
induc
bev
bevinduc
apoptosi
late
time
postinfect
viral
progeni
produc
could
facilit
viral
dissemin
vivo
contribut
viral
pathogenesi
torovirus
enter
probabl
respiratori
virus
infect
differ
anim
speci
human
caus
diarrhea
positivesens
singl
strand
rna
envelop
virus
togeth
coronavirus
belong
coronavirida
famili
nidoviral
order
four
toroviru
speci
recogn
ictv
establish
accord
anim
host
infect
bovin
toroviru
btov
porcin
toroviru
ptov
human
toroviru
htov
equin
toroviru
etov
ictv
web
site
wwwictvonlineorg
latter
viru
first
toroviru
identifi
isol
faec
hors
bern
switzerland
name
bern
viru
bev
long
time
bev
strain
genu
could
grown
cell
cultur
therefor
thoroughli
studi
molecular
level
prototyp
member
genu
nonetheless
propag
differ
btov
strain
human
cell
line
recent
describ
toroviru
genom
consist
singl
rna
molecul
kb
two
third
contain
two
larg
overlap
open
read
frame
code
replic
machineri
last
third
genom
contain
four
open
read
frame
orf
code
spike
membran
hemagglutininesteras
nucleocapsid
n
structur
protein
bev
gene
partial
delet
compar
toroviru
strain
though
correspond
mrna
produc
sinc
identif
torovirus
poorli
studi
mani
issu
regard
toroviru
infect
remain
unexplor
significantli
littl
known
morpholog
physiolog
biochem
chang
occur
toroviru
infect
cell
investig
complex
virushost
interact
import
understand
basi
torovirusinduc
diseas
studi
toroviru
pathogenesi
perform
btov
sinc
toroviru
success
propag
experiment
infect
studi
gnotobiot
colostrum
depriv
calv
infect
oral
intranas
btov
develop
moder
sever
diarrhea
infect
anim
sacrif
sequenti
earli
stage
infect
intestin
tissu
sampl
observ
light
electron
microscopi
cytopatholog
chang
associ
btov
infect
observ
enterocyt
lower
half
villi
extend
crypt
throughout
lower
small
intestin
larg
intestin
dome
epitheli
cell
enterocyt
show
sign
sever
vacuolar
degener
necrosi
exfoli
suggest
primari
site
infect
crypt
cell
infect
cell
migrat
villou
shed
viral
cytopath
effect
cpe
develop
hand
effect
infect
host
close
relat
coronavirus
thoroughli
investig
especi
sinc
emerg
human
coronaviru
caus
sever
acut
respiratori
syndrom
sarscov
significantli
occurr
cell
death
apoptosi
observ
infect
sever
coronavirus
mous
hepat
viru
mhv
transmiss
gastroenter
viru
tgev
infecti
bronchiti
viru
ibv
canin
coronaviru
ccov
felin
infecti
periton
viru
fipv
equin
coronaviru
human
coronavirus
sarscov
induct
apoptosi
repres
one
major
compon
host
antivir
respons
nonetheless
virus
establish
intric
complex
interact
host
regul
apoptosi
ensur
success
replic
cycl
allow
product
spread
viru
progeni
neighbour
cell
fact
mani
virus
report
inhibit
apoptosi
earli
infect
facilit
viral
replic
induc
apoptosi
later
time
postinfect
inhibit
inflammatori
respons
favour
viral
dissemin
two
cellular
protein
key
effector
initi
antivir
respons
trigger
interferon
ifn
relat
induct
apoptosi
protein
kinas
r
pkr
rnase
l
protein
becom
activ
doublestrand
rna
dsrna
activ
two
protein
result
protein
synthesi
inhibit
apoptosi
upon
activ
pkr
phosphoryl
alpha
subunit
eukaryot
initi
factor
impair
activ
caus
inhibit
hostcel
translat
initi
hand
rnase
l
activ
produc
upon
dsrna
activ
synthetas
degrad
viral
host
singlestrand
rna
ssrna
includ
ribosom
rna
therefor
pkr
rnase
l
activ
effect
inhibit
viral
cellular
gene
express
ultim
consequ
activ
induct
apoptot
pathway
lead
remov
infect
cell
caspas
intracellular
proteas
cysteinedepend
aspartatespecif
proteas
play
essenti
role
apoptosi
two
main
apoptosi
pathway
regul
caspas
extrins
cell
death
receptor
pathway
intrins
mitochondri
pathway
former
initi
mainli
bind
extracellular
ligand
death
receptor
turn
aggreg
recruit
adapt
protein
molecul
lead
activ
mitochondri
pathway
activ
intracellular
signal
dna
damag
lead
releas
cytochrom
c
mitochondria
bind
adaptor
molecul
apoptot
proteas
activ
complex
bind
promot
autocleavag
pathway
converg
activ
execution
caspas
name
primari
execution
caspas
cleav
cellular
substrat
examin
lead
characterist
morpholog
featur
apoptosi
nuclear
shrink
membran
bleb
cell
death
receptor
mitochondri
apoptosi
signal
pathway
also
intersect
cleavag
bid
proapoptot
famili
member
promot
cytochrom
c
releas
mitochondria
shown
implic
apoptosi
induc
virus
report
first
biochem
studi
effect
caus
toroviru
infect
cell
show
typic
morpholog
biochem
featur
apoptosi
induc
bev
infect
cell
elucid
underli
mechan
examin
sever
apoptot
marker
found
intrins
extrins
apoptot
pathway
involv
second
like
activ
bid
cleavag
knowledg
noth
known
torovirusinduc
alter
cellular
function
signal
pathway
would
profound
impact
cell
viabil
viru
pathogenesi
equin
dermal
e
derm
cell
atcc
human
fetal
lung
fibroblast
attc
kindli
provid
r
de
groot
utrecht
univers
utrecht
netherland
r
e
randal
univers
st
andrew
scotland
uk
respect
cultur
co
humid
dulbecco
modifi
eagl
medium
dmem
invitrogen
corp
supplement
fetal
calf
serum
fc
respect
nonessenti
aminoacid
gentamicin
mgml
penicillin
uml
streptomycin
mg
ml
fungizon
mgml
equin
toroviru
bev
strain
obtain
r
de
groot
utrecht
univers
utrecht
netherland
viru
grown
e
derm
cell
partial
purifi
ultracentrifug
sucros
cushion
viru
titrat
plaqu
assay
previous
describ
prepar
partial
purifi
viru
place
open
tube
uv
lamp
philip
insid
laminar
flow
hood
maintain
expos
uv
light
min
viral
inactiv
confirm
titrat
viral
sampl
uv
irradi
phasecontrast
microscopi
e
derm
cell
mockinfect
infect
bev
plaqueform
unit
pfu
cell
plate
hour
postinfect
hpi
cell
examin
invert
phasecontrast
microscop
leica
object
imag
acquir
digit
camera
ccd
hamamatsu
orca
monolay
e
derm
cell
mockinfect
infect
bev
pfucel
fix
situ
hpi
mixtur
paraformaldehyd
pfa
glutaraldehyd
phosphat
buffer
ph
h
room
temperatur
fix
cell
remov
dish
wash
phosphat
buffer
process
embed
epoxi
resin
taab
laboratoriesengland
uk
method
previous
describ
ultrathin
section
embed
sampl
stain
satur
uranyl
acet
lead
citrat
examin
kv
jeol
tokyo
japan
electron
microscop
pictur
acquir
bioscan
digit
camera
gatan
inc
e
derm
cell
seed
plate
infect
bev
pfucel
indic
time
postinfect
cell
subject
min
puls
mciml
metci
ge
healthcar
dmem
without
met
cy
cell
extract
lyse
laemmli
buffer
bmercaptoethanol
protein
denatur
boil
min
separ
sdspage
polyacrylamid
gel
visual
stain
gel
coomassi
blue
label
protein
detect
autoradiographi
dri
gel
apoptosi
quantit
analysi
nuclear
dna
content
flow
cytometri
differ
stage
cell
cycl
percentag
cell
subg
g
dna
content
analyz
propidium
iodid
pi
stain
flow
cytometri
e
derm
cell
seed
plate
infect
bev
pfucel
experi
viru
adsorpt
cell
treat
caspas
inhibitor
zietdfmk
zlehdfmk
zvadfmk
gener
inhibitor
calbiochem
final
concentr
mm
indic
time
cell
well
collect
float
cell
taken
medium
combin
still
adher
plastic
recov
trypsin
cell
wash
icecold
phosphatebuff
salin
pb
permeabil
ethanol
pb
overnight
later
cell
wash
three
time
pb
incub
min
rnasea
mgml
stain
pi
mgml
percentag
cell
hypodiploid
dna
content
determin
flow
cytometri
data
acquir
cell
per
sampl
coulter
epic
xlmcl
cytomet
argon
laser
nuclei
stain
apoptot
cell
e
derm
cell
seed
coverslip
infect
bev
pfucel
fix
pfa
indic
time
cell
stain
hoechst
mgml
sigma
imag
obtain
leica
dmrd
epifluoresc
microscop
use
suitabl
filter
nm
analyz
rrna
degrad
e
derm
cell
seed
plate
infect
bev
pfucel
hpi
medium
remov
cell
wash
pb
lyse
ml
rlt
buffer
rneasi
mini
kit
qiagen
rna
purifi
follow
manufactur
instruct
final
rna
elut
ml
diethyl
pyrocarbonatetr
water
ml
rna
sampl
analyz
agaros
gel
stain
use
ethidium
bromid
etbr
mgml
rnase
free
condit
e
derm
cell
grown
plate
mockinfect
infect
bev
multipl
infect
pfucel
collect
hpi
cell
treat
staurosporin
nm
h
includ
assay
control
cytocrom
c
redistribut
cell
undergo
apoptosi
induc
mitochondri
pathway
indic
time
cell
collect
pb
subject
digitonin
permeabil
previous
describ
briefli
pellet
cell
resuspend
ml
isoton
sucros
buffer
mm
sucros
mm
hepe
mm
kcl
mm
mgcl
mm
edta
mm
egta
ph
contain
digitonin
sigma
min
room
temperatur
disrupt
cell
centrifug
rpm
min
solubl
cytosol
fraction
transfer
new
tube
contain
ml
sampl
buffer
digitonininsolubl
fraction
membranebound
organellar
fraction
wash
isoton
buffer
directli
disrupt
ml
laemmli
sampl
buffer
mockinfect
bevinfect
e
derm
cell
lyse
indic
time
postinfect
directli
laemmli
buffer
bmercaptoethanol
subject
subcellular
fraction
describ
protein
denatur
boil
min
protein
lysat
fraction
sdspage
transfer
nitrocellulos
membran
protran
schleicher
schuell
semidri
blot
apparatu
biorad
min
membran
block
h
pb
contain
nonfat
dri
milk
probe
differ
antibodi
rabbit
polyclon
antiparp
cell
signal
rabbit
polyclon
recogn
amino
n
carboxi
c
termin
moieti
protein
kindli
provid
dr
carrasco
cbmso
madrid
spain
polyclon
antiphosphoryl
biosourc
polyclon
santa
cruz
biotechnolog
rabbit
polyclon
antiphosphoryl
pkr
invitrogen
monoclon
antimurin
pkr
santa
cruz
biotechnolog
mous
monoclon
antibactin
abcam
rabbit
polyclon
bid
kindli
provid
dr
yin
indiana
univers
indianapoli
eeuu
mous
monoclon
anticytochrom
c
santa
cruz
biotechnolog
two
rabbit
polyclon
sera
bev
nucleocapsid
protein
antibevn
membran
protein
antibevm
respect
mous
monoclon
anti
antibodi
protein
detect
use
horseradish
peroxidaselabel
secondari
antibodi
sigma
enhanc
chemiluminesc
western
blot
detect
kit
ecl
ge
health
care
statist
analys
perform
use
student
two
tail
test
mean
standard
deviat
sampl
shown
sinc
littl
known
host
cellular
respons
toroviru
infect
decid
examin
cellular
respons
infect
bev
viru
prototyp
member
toroviru
group
recent
bev
toroviru
strain
could
grown
cell
cultur
e
derm
embryon
mule
skin
em
cell
cell
line
describ
suscept
infect
date
e
derm
cell
infect
bev
multipl
infect
pfucel
first
sign
infect
could
detect
hpi
cpe
seen
cell
compar
panel
b
e
figur
howev
extens
cpe
could
observ
hpi
fig
panel
c
f
hand
examin
electron
microscopi
e
derm
cell
infect
h
bev
pfucel
show
cell
present
characterist
sign
apoptosi
figur
show
comparison
appear
uninfect
e
derm
cell
panel
bev
infect
cell
show
apoptot
characterist
disorgan
nucleu
chromatin
condens
membran
bleb
cell
disassembl
vesicl
panel
b
number
cell
show
morpholog
readili
increas
time
postinfect
shown
agreement
cpe
observ
phasecontrast
microscopi
result
suggest
bev
caus
apoptosi
late
time
infect
cycl
respons
mammalian
cell
varieti
stimuli
stressinduc
condit
caus
apoptosi
viral
infect
involv
rapid
inhibit
protein
synthesi
analyz
whether
protein
synthesi
affect
bev
infect
e
derm
cell
infect
bev
pfucel
metabol
label
metci
min
indic
time
postinfect
rang
hpi
fig
protein
analyz
sdspage
gel
stain
coomassi
blue
later
subject
autoradiographi
signific
gener
reduct
protein
synthesi
observ
hpi
although
clear
decreas
alreadi
observ
hpi
imag
coomassi
blue
stain
gel
show
similar
amount
protein
load
lane
fig
significantli
two
band
correspond
protein
molecular
mass
could
first
appreci
autoradiogram
hpi
intens
band
highli
increas
hpi
diminish
thereaft
two
band
correspond
bev
structur
protein
n
respect
although
rel
mobil
sdspage
slightli
higher
previous
describ
ident
protein
confirm
analysi
sampl
western
blot
antibevn
antibevm
antibodi
fig
pattern
appear
protein
similar
observ
metabol
label
fig
interestingli
although
metabol
label
studi
indic
n
synthesi
decreas
late
time
infect
cycl
protein
still
detect
western
blot
analysi
suggest
protein
remain
stabl
late
time
point
addit
fig
high
molecular
weight
protein
observ
intens
increas
hpi
diminish
hpi
onward
label
solid
arrowhead
could
correspond
protein
precursor
moreov
two
addit
faint
band
rang
label
empti
arrowhead
could
observ
hpi
could
correspond
cleav
product
western
blot
monoclon
antibodi
recogn
protein
observ
precursor
hpi
precursor
one
cleav
product
hpi
onward
fig
investig
effect
bev
infect
search
cell
type
could
infect
bev
thu
sever
cell
line
differ
origin
subject
infect
trial
bev
found
viru
could
also
grow
human
cell
though
viral
replic
cycl
slower
cell
type
et
al
unpublish
result
therefor
carri
similar
experi
describ
perform
metabol
label
metci
cell
infect
bev
pfucel
overal
protein
synthesi
reduct
similar
observ
e
derm
cell
also
observ
cell
hpi
fig
intens
whole
protein
profil
visual
coomassi
blue
stain
similar
indic
equival
amount
protein
load
line
fig
also
viral
protein
detect
although
show
delay
synthesi
respect
e
derm
cell
first
detect
hpi
ident
bev
n
protein
respect
also
confirm
western
blot
fig
although
autoradiogram
could
distinguish
high
molecular
band
correspond
protein
precursor
cleav
product
among
cellular
protein
cell
fig
western
blot
anti
monoclon
antibodi
could
see
precursor
hpi
precursor
one
cleav
product
hpi
onward
fig
result
show
bev
infect
cell
synthesi
cellular
viral
protein
drastic
inhibit
late
time
postinfect
pkr
phosphoryl
bev
infect
cell
common
mechan
downregul
protein
synthesi
apoptosi
phosphoryl
translat
initi
factor
pkr
one
three
serthr
cellular
protein
kinas
known
phosphoryl
respons
viral
infect
lead
block
translat
initi
activ
pkr
occur
autophosphoryl
upon
bind
dsrna
case
virusinfect
cell
gener
result
viral
replic
simpli
byproduct
origin
replic
viral
genom
observ
accumul
dsrna
gener
intermedi
product
viral
replic
toroviru
infect
cell
vila
et
al
unpublish
result
henc
sought
investig
whether
becom
phosphoryl
bev
infect
cell
e
derm
cell
infect
bev
pfucel
indic
time
postinfect
cell
collect
subject
western
blot
analysi
shown
figur
transient
phosphoryl
observ
cell
line
start
hpi
decreas
hpi
therefor
next
want
determin
pkr
could
respons
phosphoryl
bev
infect
significantli
cell
line
pkr
phosphoryl
first
observ
hpi
increas
hpi
fig
e
derm
cell
similar
phosphoryl
dynam
observ
pkr
western
blot
analysi
sampl
antibodi
total
pkr
also
perform
sampl
load
control
howev
antibodi
test
pkr
fail
recogn
protein
e
derm
cell
result
indic
protein
synthesi
blockad
observ
bev
infect
seem
relat
phosphoryl
could
caus
pkr
dsrna
also
known
activ
cellular
rnase
l
rna
degrad
rnase
l
therefor
anoth
cellular
mechan
implic
protein
synthesi
inhibit
translat
level
apoptosi
induc
henc
want
determin
whether
rrna
degrad
occur
bev
infect
cell
analyz
rrna
pattern
rrna
analyz
e
derm
cell
infect
bev
pfucel
indic
time
hpi
shown
figur
similar
rrna
degrad
pattern
observ
cell
line
rna
degrad
earlier
time
point
degrad
rna
clearli
appar
cell
line
hpi
therefor
result
reinforc
hypothesi
bev
caus
apoptosi
infect
cell
suggest
protein
synthesi
inhibit
also
relat
rna
degrad
caspas
central
execution
apoptosi
involv
morpholog
chang
observ
apoptot
cell
two
wellknown
substrat
execution
caspas
poli
adpribosyl
protein
enzym
implic
dnadamag
repair
initi
factor
scaffold
protein
translat
initi
complex
caspasemedi
cleavag
produc
c
termin
fragment
n
termin
fragment
render
protein
inact
protein
cleav
two
differ
place
apoptosi
give
rise
central
fragment
two
fragment
correspond
n
c
termini
determin
whether
caspasecascad
system
activ
upon
bev
infect
potenti
degrad
factor
studi
e
derm
cell
infect
bev
pfucel
cell
extract
collect
hpi
mockinfect
cell
use
control
sampl
analyz
sdspage
polyacrylamid
gel
subject
western
blot
analysi
commerci
antiparp
antibodi
recogn
intact
protein
fragment
polyclon
antibodi
recogn
n
c
termini
appear
parp
fragment
concomit
decreas
band
start
hpi
e
derm
cell
hpi
cell
fig
upper
panel
present
similar
pattern
appear
band
concomit
decreas
band
hpi
onward
e
derm
cell
hpi
cell
fig
bottom
panel
result
conclud
bevinduc
apoptosi
involv
caspas
activ
also
sought
determin
whether
viru
replic
prerequisit
virusinduc
apoptosi
e
derm
cell
inocul
bev
pfucel
equival
amount
uvinactiv
bev
hpi
cell
harvest
analyz
western
blot
antiparp
antibodi
observ
cpe
cell
treat
uvinactiv
viru
data
shown
neither
two
caspas
substrat
process
cell
fig
suggest
bev
apoptosi
trigger
depend
upon
viral
replic
one
main
characterist
apoptot
cell
nuclear
morpholog
alter
due
dna
fragment
chromatin
condens
apoptot
bodi
format
previous
observ
electron
microscopi
hpi
nuclei
bevinfect
cell
disorgan
want
examin
nuclear
morpholog
later
time
postinfect
therefor
e
derm
cell
infect
bev
pfucel
mockinfect
kinet
studi
perform
fix
cell
pfa
differ
time
hpi
nuclei
stain
hoechst
observ
fluoresc
microscopi
fig
nuclei
control
cell
evenli
stain
abnorm
brighter
smaller
nuclei
instead
observ
bev
infect
cell
late
time
postinfect
hpi
found
small
percentag
apoptot
nuclei
increas
hpi
hpi
percentag
apoptot
nuclei
record
born
mind
time
postinfect
mani
cell
alreadi
detach
float
cultur
medium
therefor
percentag
apoptot
cell
time
point
underestim
approach
therefor
order
quantifi
effici
kinet
appear
apoptot
nuclei
analyz
nuclear
dna
content
flow
cytometri
pi
stain
apopot
nuclei
show
reduc
fluoresc
compar
nonapoptot
nuclei
appear
broad
subg
g
peak
henc
e
derm
cell
infect
bev
pfucel
harvest
monolay
medium
hpi
stain
pi
analyz
flow
cytometri
fig
show
repres
exampl
cell
cycl
profil
obtain
e
derm
cell
could
observ
gradual
increas
amount
cell
present
subg
g
peak
increas
time
postinfect
although
broader
peak
observ
e
derm
cell
cell
assay
perform
three
time
result
three
experi
repres
fig
shown
figur
e
derm
cell
infect
bev
appear
subg
g
peak
hpi
percentag
progress
increas
hpi
apoptosi
respect
observ
previou
analysi
protein
synthesi
cleavag
caspas
substrat
cell
apoptot
process
delay
apoptot
cell
hpi
increas
hpi
determin
bev
infect
caus
apoptosi
e
derm
cell
know
caspas
cascad
involv
want
know
upstream
caspas
therefor
apoptot
pathway
death
receptor
andor
mitochondri
pathway
could
involv
e
derm
cell
infect
bev
pfucel
treat
gener
caspas
inhibitor
zvadfmk
inhibitor
zietdfmk
inhibitor
zlehdfmk
percentag
cell
subg
g
zone
determin
hpi
flow
cytometri
pi
stain
assay
perform
twice
observ
e
derm
cell
gener
caspas
inhibitor
clearli
protect
cell
bevinduc
apoptosi
apoptosi
respect
zvadfmk
treat
cell
vs
nontreat
cell
two
inhibitor
produc
partial
reduct
apoptosi
level
decreas
higher
inhibitor
apoptosi
respect
inhibitor
apoptosi
respect
fig
b
e
derm
cell
differ
level
apoptosi
nontreat
cell
cell
treat
inhibitor
statist
signific
nonetheless
western
blot
analysi
observ
clear
effect
inhibitor
cleavag
caspas
substrat
untreat
inhibitortr
e
derm
cell
infect
bev
collect
hpi
respect
cell
extract
incub
antibodi
antibevn
antiactin
antibodi
infect
load
control
respect
fig
untreat
bevinfect
cell
intens
band
correspond
cleav
product
observ
lane
protein
almost
total
protect
cleavag
gener
caspas
inhibitor
lane
partial
protect
lane
lane
inhibitor
interestingli
cleavag
parp
significantli
prevent
caspas
inhibitor
slightli
inhibit
use
higher
concentr
mm
data
shown
result
also
agreement
obtain
observ
infect
cell
use
light
field
microscopi
shown
reveal
trend
wherebi
cell
damag
induc
apoptosi
higher
untreat
cell
follow
first
place
cell
treat
inhibitor
secondli
cell
treat
inhibitor
cell
treat
gener
caspas
inhibitor
whole
result
indic
although
cell
death
receptor
mitochondri
pathway
implic
bev
induct
apoptosi
mitochondri
pathway
could
secondarili
activ
cleavag
bid
ascertain
involv
mitochondri
pathway
bevinduc
apoptosi
analyz
cellular
distribut
cytochrom
c
differ
time
postinfect
assay
e
derm
mockinfect
cell
cell
infect
bev
pfucel
h
fraction
cytosol
membranebound
organellar
fraction
previous
describ
analyz
western
blot
cell
treat
staurosporin
use
posit
control
mitochondri
pathway
activ
shown
figur
mockinfect
e
derm
cell
cytochrom
c
exclus
found
insolubl
membran
fraction
lane
bevinfect
cell
cytochrom
c
releas
cytosol
could
observ
hpi
lane
similar
rate
staurosporinetr
cell
lane
cell
cytochrom
c
clearli
present
mitochondria
contain
fraction
differ
treat
cell
could
bare
observ
cytosol
fraction
cell
infect
hpi
clearli
observ
cytosol
fraction
staurosporinetr
cell
result
agreement
result
indic
cell
apoptot
process
occur
lower
rate
see
fig
slight
reduct
percentag
apoptot
cell
upon
treatment
infect
cell
inhibitor
could
suggest
mitochondri
apoptot
pathway
may
trigger
cleavag
proapoptot
protein
bid
studi
potenti
involv
bid
activ
examin
bid
proteolyt
process
bev
infect
cell
cellular
fraction
previous
obtain
also
analyz
antibid
antibodi
shown
figur
cleavag
bid
proapoptot
activ
form
tbid
could
observ
cell
line
infect
bev
lane
hand
mockinfect
cell
lane
cell
treat
staurosporin
lane
intact
form
bid
detect
result
confirm
mitochondri
pathway
involv
bevinduc
apoptosi
point
cleavag
bid
trigger
factor
analyz
potenti
effect
apoptosi
bev
replic
e
derm
cell
infect
bev
pfucel
absenc
presenc
zvadfmk
mm
supernat
collect
hpi
viral
titer
determin
plaqu
assay
experi
perform
triplic
shown
figur
signific
differ
viru
yield
obtain
time
point
analyz
absenc
presenc
gener
caspas
inhibitor
either
cell
line
similar
result
obtain
experi
perform
infect
cell
line
bev
low
multipl
infect
pfucel
data
shown
therefor
result
indic
caspasemedi
apoptosi
requir
viru
replic
andor
releas
progeni
virion
torovirus
scarc
studi
date
henc
littl
known
toroviru
effect
infect
cell
virushost
interact
establish
infect
studi
pathogenesi
caus
btov
experiment
infect
calv
describ
viru
caus
cpe
epitheli
cell
intestin
result
sever
vacuolar
degener
necrosi
exfoli
enterocyt
induc
villou
atrophi
crypt
hyperplasia
case
fuse
villi
hand
initi
character
studi
bev
infect
e
derm
em
cell
infect
vitro
show
cytopatholog
chang
appar
hpi
cell
obtain
similar
result
e
derm
cell
infect
multipl
infect
pfucel
hpi
cell
show
characterist
cythopat
titrat
graphic
represent
media
standard
deviat
three
independ
experi
statist
signific
differ
valu
absenc
presenc
zvadfmk
two
cell
line
time
point
test
student
test
featur
cell
round
detach
howev
extens
cpe
observ
hpi
mani
cell
float
medium
obtain
detail
imag
cpe
caus
bev
infect
cell
examin
electron
microscopi
observ
hpi
bev
infect
cell
exhibit
morpholog
chang
characterist
apoptot
cell
condens
nucleu
membran
bleb
alter
mitochondria
cell
disassembl
vesicl
suggest
bev
infect
could
induc
apoptosi
fact
could
relat
cpe
describ
btov
infect
anim
list
virus
caus
apoptosi
infect
cell
expand
significantli
last
two
decad
includ
sever
coronavirus
investig
whether
bev
actual
caus
apoptosi
sought
obtain
biochem
evid
e
derm
cell
might
optim
investig
hostinteract
like
mani
cellular
protein
would
recogn
avail
antibodi
therefor
use
also
cell
identifi
suscept
bev
infect
perform
metabol
label
infect
e
derm
cell
observ
protein
synthesi
inhibit
cellular
viral
protein
hpi
e
derm
cell
hpi
cell
sever
factor
like
involv
induct
protein
synthesi
inhibit
common
apoptot
onset
gener
dsrna
genom
replic
usual
factor
among
rna
virus
includ
coronavirus
fact
observ
dsrna
accumul
e
derm
cell
infect
bev
vila
et
al
unpublish
data
dsrna
turn
activ
innat
immun
respons
viral
infect
dsrna
bind
activ
two
apoptosi
trigger
lead
protein
synthesi
inhibit
one
hand
activ
synthetas
lead
activ
latent
rnase
l
degrad
ssrna
cleavag
rrna
observ
cell
line
hpi
suggest
rnase
l
could
activ
cleavag
rrna
describ
occur
mhv
infect
cell
although
report
author
show
cleavag
earli
event
mhv
infect
probabl
independ
apoptosi
argu
anoth
rnase
cellular
viral
origin
rnase
l
respons
cleavag
addit
propos
anoth
yet
unidentifi
rnase
involv
rna
specif
cleavag
apoptosi
therefor
specif
assay
requir
determin
whether
rrna
cleavag
observ
bev
infect
cell
mediat
rnase
l
andor
ribonucleas
hand
dsrna
also
activ
endogen
pkr
lead
phosphoryl
show
pkr
becom
phosphoryl
upon
bev
infect
howev
discard
possibl
two
virusactiv
cellular
kinas
known
phosphoryl
pkrlike
endoplasm
reticulum
kinas
perk
gener
control
kinas
might
respons
bevinduc
phosphoryl
regard
describ
cell
sarscov
induc
apoptosi
via
pkr
phosphoryl
howev
two
event
seem
connect
sinc
inhibit
pkr
express
prevent
apoptosi
phosphoryl
case
perk
found
respons
kinas
therefor
rna
degrad
plu
phosphoryl
found
bev
infect
cell
could
contribut
protein
synthesi
inhibit
upon
bev
infect
unmistak
sign
apoptosi
induct
activ
caspas
cascad
result
proteolyt
cleavag
seri
protein
known
exert
import
cellular
function
show
cleavag
parp
substrat
readili
occur
bevinfect
cell
e
derm
timedepend
manner
result
also
suggest
degrad
could
anoth
factor
contribut
observ
protein
synthesi
inhibit
addit
nuclei
morpholog
chang
characterist
apoptot
cell
death
loss
nuclear
dna
content
time
postinfect
determin
pi
stain
analysi
flow
cytometri
consist
notion
bev
caus
caspasemedi
apoptosi
studi
apoptot
factor
nuclear
dna
content
sever
time
postinfect
indic
e
derm
cell
chronolog
process
could
follow
first
pkr
phosphoryl
start
hpi
rrna
degrad
parp
cleavag
caspas
protein
synthesi
inhibit
hpi
final
nuclei
degrad
hpi
analysi
paramet
bev
infect
cell
indic
apoptot
process
occur
later
time
postinfect
observ
agreement
lower
infect
rate
cell
compar
e
derm
cell
determin
lower
viral
yield
see
fig
untreat
cell
lower
viral
protein
express
fig
moreov
result
also
indic
caspasemedi
apoptosi
requir
activ
bev
replic
regard
could
observ
either
characterist
morpholog
featur
apoptosi
cleavag
parp
e
derm
cell
inocul
uvinactiv
viru
similar
result
describ
sarscov
case
mhv
report
viral
replic
requir
suggest
viru
fusion
trigger
viru
bind
cell
receptor
suffici
initi
apoptosi
signal
fa
activ
analysi
dna
content
cleavag
well
de
visu
examin
cell
infect
presenc
caspas
inhibitor
show
intrins
extrins
apoptot
pathway
involv
moreov
observ
cytochrom
c
releas
cytoplasm
show
mitochondri
pathway
involv
nonetheless
cell
death
receptor
pathway
seem
predomin
cell
line
sinc
determin
analysi
nuclear
dna
content
flow
cytometri
inhibitor
extrins
pathway
caus
reduct
apoptosi
e
derm
cell
respect
compar
reduct
respect
observ
treatment
inhibitor
mitochondri
pathway
result
suggest
mitochondri
pathway
activ
indirectli
cleavag
proapoptot
famili
member
bid
shown
occur
ccov
mhv
infect
cell
question
aris
extrins
pathway
activ
bev
infect
regard
fasmedi
signal
implic
apoptosi
respons
infect
differ
virus
review
activ
fa
pathway
may
occur
extracellularli
bind
fa
fa
ligand
fasl
intracellularli
signal
pathway
sever
studi
indic
pkr
involv
activ
fasdepend
apoptosi
independ
fasl
respons
variou
stressinduc
stimuli
includ
viru
infect
influenza
viru
infect
earli
activ
pkr
seem
import
upregul
fa
gene
express
induct
apoptosi
regard
observ
earli
induct
fa
gene
express
level
transcript
upon
bev
infect
unpublish
result
thu
possibl
case
influenza
viru
virus
fa
signal
pathway
might
respons
apoptosi
induct
bev
infect
cell
merit
investig
interestingli
parp
cleavag
seem
inhibit
significantli
caspas
inhibitor
use
cleavag
parp
consid
biochem
hallmark
apoptosi
howev
regard
special
caspas
substrat
sinc
cleav
therefor
oppos
substrat
known
cleav
apoptosi
gelsolin
afodrin
lamin
probabl
parp
cleav
absenc
presenc
specif
inhibitor
moreov
suggest
effici
parp
cleavag
therefor
possibl
due
redund
parp
cleavag
still
proceed
presenc
caspas
inhibitor
although
report
cleavag
parp
inhibit
jurkat
cell
treat
zvadfmk
mm
indic
inhibitor
also
block
celltyp
specif
differ
abund
caspas
could
explain
discrep
specif
experi
would
requir
ascertain
caspas
cleav
parp
cell
infect
bev
presenc
gener
caspas
inhibitor
zvadfmk
result
indic
apoptosi
affect
viru
replic
andor
releas
vitro
observ
inhibit
apoptot
process
treat
bev
infect
cell
either
low
high
multipl
infect
gener
caspas
inhibitor
influenc
amount
viru
releas
medium
significantli
bev
infect
cell
maximum
viral
progeni
alreadi
obtain
hpi
therefor
viru
seem
complet
replic
cycl
onset
apoptosi
common
strategi
use
sever
rna
virus
specif
coronavirus
overcom
effect
prematur
cell
death
summari
studi
show
bev
infect
lead
caspasedepend
apoptot
cell
death
e
derm
cell
apoptot
process
induc
bev
trigger
late
time
postinfect
viral
progeni
produc
howev
toroviru
infect
anim
apoptosi
could
favour
viral
infect
like
facilit
viral
dissemin
pathogenesi
suggest
great
number
virus
mainli
rna
virus
induc
apoptosi
final
stage
replic
cycl
apoptot
death
infect
cell
caus
tissu
destruct
case
toroviru
associ
gastroenter
could
relat
apoptosi
mucosa
epitheli
cell
regard
previous
hypothes
coronavirus
apoptosi
could
patholog
basi
lesion
diseas
tissu
alter
work
requir
delin
pathway
involv
cell
death
identifi
viral
cellular
factor
involv
modul
torovirusinduc
apoptosi
work
serv
start
point
understand
virushost
interact
toroviru
infect
field
research
remain
almost
unexplor
yet
